The incidences of and risk factors for severe retinopathy requiring photocoagulation and albuminuria in Japanese patients with childhood-onset type 1 diabetes
- PMID: 30603359
- PMCID: PMC6224943
- DOI: 10.1007/s13340-017-0336-9
The incidences of and risk factors for severe retinopathy requiring photocoagulation and albuminuria in Japanese patients with childhood-onset type 1 diabetes
Abstract
The aim of this study was to clarify the incidences of and the risk factors for severe retinopathy requiring photocoagulation therapy and albuminuria in Japanese patients with childhood-onset type 1 diabetes mellitus. A total of 756 patients from a cohort study by the Japanese Study Group of Insulin Therapy for Childhood and Adolescent Diabetes were included in the study. Patients were registered in 1995 or 2000, and HbA1cwas measured every 4 months and analyzed in central hospital for an average of 6 years. The presence of severe retinopathy requiring laser photocoagulation and the presence of albuminuria was checked for during the period 2010-2011. During a median of 18 (range: 15-21) years, 34 out of 756 patients underwent laser photocoagulation and 57 out of 605 patients developed albuminuria. A Cox proportional hazards model showed that the risk of severe retinopathy requiring laser photocoagulation increased by 1.15 (95% confidence interval [CI] 1.03-1.29, p = 0.012) with each increase of a year in the age at onset, by 4.03 (95% CI 1.20-13.5, p = 0.024) in females, and by 2.05 (95% CI 1.69-2.49, p < 0.0001) with each increase of 1% in HbA1c. The risk of albuminuria increased significantly, by 1.09 (95% CI 1.01-1.18 p = 0.037), with each increase of a year in the age at onset and by 2.38 (95% CI 1.93-2.97 p < 0.0001) with each increase of 1% in HbA1c. In Japanese patients with childhood-onset type 1 diabetes, older age at the onset of diabetes, female rather than male gender, and higher HbA1c were found to increase the risk of requiring photocoagulation. No patients with HbA1c < 7.5% developed severe retinopathy requiring photocoagulation therapy. The risk of developing albuminuria increased with age at onset of diabetes and HbA1c. Female gender was a strong risk factor for severe retinopathy requiring photocoagulation, but not for albuminuria.
Keywords: Child-onset type 1 diabetes; Laser photocoagulation; Macroalbuminuria; Microalbuminuria; Microangiopathy.
Conflict of interest statement
Tatsuhiko Urakami has served in advisory panels for Novo Nordisk and Sanofi, and has served on speakers’ bureaus for Sanofi.All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent or a substitute for it was obtained from all patients before they were included in the study.
Figures


Similar articles
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.Diabetes Res Clin Pract. 1995 May;28(2):103-17. doi: 10.1016/0168-8227(95)01064-k. Diabetes Res Clin Pract. 1995. PMID: 7587918 Clinical Trial.
-
Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.Acta Ophthalmol. 2018 Aug;96(5):459-464. doi: 10.1111/aos.13815. Acta Ophthalmol. 2018. PMID: 30188024 Free PMC article.
-
A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients.Diabetologia. 1992 Nov;35(11):1049-54. doi: 10.1007/BF02221680. Diabetologia. 1992. PMID: 1473614
-
Bjerrum lecture. Treatment of diabetic retinopathy with photocoagulation. Results of photocoagulation therapy of proliferative retinopathy in childhood-onset and maturity-onset diabetes and an approach to the dosage in photocoagulation.Acta Ophthalmol (Copenh). 1983 Oct;61(5):756-68. doi: 10.1111/j.1755-3768.1983.tb01457.x. Acta Ophthalmol (Copenh). 1983. PMID: 6659884
-
Type 1 diabetes patients with severe non-proliferative retinopathy may benefit from panretinal photocoagulation.Acta Ophthalmol Scand. 2003 Jun;81(3):221-5. doi: 10.1034/j.1600-0420.2003.00050.x. Acta Ophthalmol Scand. 2003. PMID: 12780397 Clinical Trial.
Cited by
-
Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.J Diabetes. 2024 Feb;16(2):e13486. doi: 10.1111/1753-0407.13486. Epub 2023 Oct 18. J Diabetes. 2024. PMID: 37853936 Free PMC article.
-
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2. Cochrane Database Syst Rev. 2023. PMID: 36815723 Free PMC article. Review.
References
-
- Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of type 1 diabetes: the Linkoping Diabetes Complications Study. Diabetologia. 2004;47:1266–1272. doi: 10.1007/s00125-004-1431-6. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous